| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,327 |
2,306 |
$114K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,787 |
3,515 |
$74K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,135 |
1,111 |
$33K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
393 |
387 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
69 |
68 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
679 |
667 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
66 |
66 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
151 |
147 |
$1K |
| 81003 |
|
642 |
626 |
$942.68 |
| 99000 |
|
170 |
167 |
$575.47 |
| 93000 |
|
27 |
27 |
$412.38 |
| 94664 |
|
59 |
59 |
$391.12 |
| 71046 |
Radiologic examination, chest; 2 views |
16 |
14 |
$325.38 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
25 |
25 |
$292.77 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
30 |
30 |
$31.99 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
155 |
149 |
$17.53 |